„Healthcare-Märkte im Umbruch: Wie COVID-19 die Transformation des deutschen Gesundheitsmarkts beschleunigt.“ (2022)
How COVID-19 is accelerating the transformation of the German healthcare market
Even before the coronavirus pandemic, the healthcare sector with all its exciting submarkets was one of the most dynamic markets in Germany. Against the backdrop of omnipresent megatrends such as individualisation and digitalisation, COVID-19 has now accelerated these existing developments enormously.
The healthcare markets are currently undergoing probably their most profound upheavals ever. And all players involved need to organise them in the best possible way!
Our Pharma & Health research team is taking two years of the pandemic as an opportunity to sketch a current picture of the healthcare industry here.
We show you, as a healthcare provider, how the COVID-19 pandemic is dynamising existing trends and what implications and changes are emerging in the course of this change from a market research perspective. We hereby trace the day-to-day activities of the basic players/HCPs for you in an overall evaluation.
For whom are the insights interesting?
The whitepaper is aimed in particular at players in the healthcare sector, especially pharmaceuticals, OTC, medical technology and digital health.
Key data on the whitepaper
Publication: 2022
Method: Combination of qualitative and quantitative research approaches.
This whitepaper is only available in German!
Get free insights now
Simply fill in the contact form and we will send you the whitepaper free of charge.
It is only available in German.
Central research questions
- How has COVID-19 influenced the transformation of the German healthcare market?
- What are the challenges and opportunities in patient care?
Your key benefits
- You will receive 5 key takeaways about the healthcare markets.
- You will learn about the impact of COVID-19 on the healthcare market
- You will gain insights into the development and acceptance of digital healthcare solutions
Do you have questions about the whitepaper?
We will be happy to advise you.
Soo-Youn Lee
Research Manager
GIM Health
Doris Fuchs
Research Director
Head of GIM Health
Dr. Hannes Fernow
Foresight Director
GIM foresight